Anthony Fauci
Anthony Fauci
Anthony Stephen "Tony" Fauciis an American immunologist who has made substantial contributions to HIV/AIDS research and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases...
NationalityAmerican
ProfessionScientist
Date of Birth24 December 1940
CountryUnited States of America
came diminished hidden levels pool three virus weeks within
Even in individuals in which we diminished the pool of the reservoir, the hidden reservoir, to levels that were essentially non-detectable ... the virus came right back within two to three weeks in essentially everyone.
available currently eliminate eradicate given virus
It does tell us is that given the currently available regimens that we have of anti-viral drugs that we are not going to eliminate or eradicate the virus from individuals,
alter blunt burst course early enormous initial prevent production virus
Vaccines, if they can blunt that initial, enormous burst of virus production early on, even if it doesn't prevent initial infection, may dramatically alter the course of infection,
bring jump looking millions ready viruses
I think it would be over-exaggeration to think that there are millions of viruses ready to jump on us and bring us back to the 14th century. That would be looking over a ledge that isn't there.
care general health low people sars virus vulnerable
Some of the most vulnerable people to getting the SARS virus are health care providers. The general public, walking in the street, there is really not that much risk at all. It's a very, very low risk - a very, very low risk.
anthrax body danger direct easily unlike virus
It's a virus that's easily transmitted from person to person through aerosolized droplets from saliva and other body fluids, ... It is unlike anthrax in that it can be transmitted from person to person and not just a danger by a direct contact.
burst cells expansion ingenious mechanism uses virus
It is an ingenious mechanism that the virus uses by having this big burst of expansion and the cells respond,
ebola vaccines viruses
The launch of phase 1 Ebola vaccine studies is a first step in developing a vaccine that could be licensed and used in the field to protect not only the front line health care workers but also those living in areas where Ebola virus exists.
unique viruses hiv
The nature of a protective immune response to HIV is still unclear. Because in a very, very unique manner, unlike virtually any other microbe with which we're familiar, the HIV virus has evolved in a way that the immune system finds it very difficult, if not impossible, to deal with the virus.
levels viruses difficult
When you put someone on therapy, you lower the level of virus such that it makes it very difficult for them to infect others.
true
We have to see if it is true and if we can do anything about it,
came fact hoped line percent response
We hoped to see a 75 percent response rate, but the fact it came in at 50 percent is not way out of line for our expectations.
course early
We now know that these reservoirs are established very early in the course of infection.
albeit good high immune news spur vaccine
We have a vaccine we know can spur an immune response, albeit at very high doses. We're going in the right direction. The sobering news is we have a long way to go. So it's muted good news.